Pneumocystis jirovecii Genotype Associated with Increased Death Rate of HIV-infected Patients with Pneumonia

Rabodonirina, Meja; Vaillant, Laetitia; Taffé, Patrick; Nahimana, Aimable; Gillibert, René-Pierre; Vanhems, Philippe; Hauser, Philippe M.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Pneumocystis jirovecii Genotype Associated with Increased Death Rate of HIV-infected Patients with Pneumonia

Published Date:

Jan 2013

Source:

Emerg Infect Dis. 19(1):21-28.

[PDF - 869.37 KB]

Details:

Personal Authors:

Rabodonirina, Meja ; Vaillant, Laetitia ; Taffé, Patrick ; Nahimana, Aimable ; Gillibert, René-Pierre ; ... More ▼

Keywords:

[+]

Description:

Pneumocystis jirovecii dihydropteroate synthase (DHPS) mutations have been associated with failure of sulfa prophylaxis; their effect on the outcome of patients with P. jirovecii pneumonia (PCP) remains controversial. P. jirovecii DHPS polymorphisms and genotypes were identified in 112 cases of PCP in 110 HIV-infected patients by using PCR single-strand conformation polymorphism. Of the 110 patients observed, 21 died; 18 of those deaths were attributed to PCP. Thirty-three percent of the PCP cases involved a P. jirovecii strain that had 1 or both DHPS mutations. The presence or absence of DHPS mutations had no effect on the PCP mortality rate within 1 month, whereas P.jirovecii type 7 and mechanical ventilation at PCP diagnosis were associated with an increased risk of death caused by PCP. Mechanical ventilation at PCP diagnosis was also associated with an increased risk of sulfa treatment failure at 5 days.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Supporting Files:

12-0140-F.gif	image/gif
12-0140-F.jpg	image/jpeg
12-0140.nxml	text/plain
license.txt	text/plain

No Related Documents.

You May Also Like:

Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France

Personal Author:

Roux, Antoine; Canet, Emmanuel; Valade, Sandrine; Gangneux-Robert, Florence; Hamane, Samia; Lafabrie, Ariane; Maubon, Daniéle; Debourgogne, Anne; Le Gal, Soléne; Dalle, Fréderic; Leterrier, Marion; Toubas, Dominique; Pomares, Christelle; Bellanger, Anne Pauline; Bonhomme, Julie; Berry, Antoine; Durand-Joly, Isabelle; Magne, Denis; Pons, Denis; Hennequin, Christophe; Maury, Eric; Roux, Patricia; Azoulay, Élie;

Published:

Sep 2014

Source:

Emerg Infect Dis. 20(9):1490-1497.

Description:

Pneumocystis jirovecii pneumonia (PCP) in patients without AIDS is increasingly common. We conducted a prospective cohort study of consecutive patients with proven PCP; of 544 patients, 223 (41%) had AIDS (AIDS patients) and 321 (59%) had other immun...

File Type:

[PDF - 516.87 KB]
Molecular Evidence of Interhuman Transmission of Pneumocystis Pneumonia among Renal Transplant Recipients Hospitalized with HIV-Infected Patients

Personal Author:

Rabodonirina, Meja; Vanhems, Philippe; Couray-Targe, Sandrine; Gillibert, René-Pierre; Ganne, Christell; Nizard, Nathalie; Colin, Cyrille; Fabry, Jacques; Touraine, Jean-Louis; van Melle, Guy; Nahimana, Aimable; Francioli, Patrick; Hauser, Philippe M.;

Published:

Oct 2004

Source:

Emerg Infect Dis. 10(10):1766-1773.

Description:

Ten Pneumocystis jirovecii pneumonia (PCP) cases were diagnosed in renal transplant recipients (RTRs) during a 3-year period. Nosocomial transmission from HIV-positive patients with PCP was suspected because these patients shared the same hospital bu...

File Type:

[PDF - 297.85 KB]
Prescription of Pneumocystis jiroveci pneumonia prophylaxis in HIV-infected patients

Personal Author:

Lin, Xia; Garg, Shikha; Mattson, Christine L.; Luo, Qingwei; Skarbinski, Jacek;

Published:

Sep 14 2016

Source:

J Int Assoc Provid AIDS Care. 15(6):455-458.

Description:

The US treatment guidelines recommend Pneumocystis jiroveci pneumonia (PCP) prophylaxis for all HIV-infected persons with a CD4 count <200 cells/mm(3) (ie, eligible for PCP prophylaxis). However, some studies suggest PCP prophylaxis may be unneces...

Public Access
Available on:

November 01, 2017
Antiretroviral Therapy during Tuberculosis Treatment and Marked Reduction in Death Rate of HIV-Infected Patients, Thailand1

Personal Author:

Akksilp, Somsak; Karnkawinpong, Opart; Wattanaamornkiat, Wanpen; Viriyakitja, Daranee; Monkongdee, Patama; Sitti, Walya; Rienthong, Dhanida; Siraprapasiri, Taweesap; Wells, Charles D.; Tappero, Jordan W.; Varma, Jay K.;

Published:

Jul 2007

Source:

Emerg Infect Dis. 13(7):1001-1007.

Description:

Antiretroviral therapy (ART) is lifesaving in patients with advanced HIV infection, but the magnitude of benefit in HIV-infected patients receiving tuberculosis (TB) treatment remains uncertain, and population-based data from developing countries are...

File Type:

[PDF - 102.99 KB]
How can this be? Preventing death in patients with HIV-associated tuberculosis

Personal Author:

Marston, Barbara J.; De Cock, Kevin M.;

Published:

May 2012

Source:

Int J Tuberc Lung Dis. 16(5):569-570.

File Type:

[PDF - 40.82 KB]